ANTRIABIO INC has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in Brazil, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, chemical engineering and biotechnology are XSPRAY PHARMA AB PUBL, XSPRAY MICROPARTICLES AB and SAVARA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Mexico | 3 | |
#7 | China | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | South Africa | 2 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Separation | |
#5 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Rosendahl Mary S | 13 |
#2 | Mantripragada Sankaram B | 13 |
#3 | Gomez Eliana B | 7 |
#4 | Sebring Greg Bryden | 6 |
#5 | Lewis Danny | 4 |
#6 | Hinds Kenneth | 4 |
#7 | Mary S Rosendahl | 4 |
#8 | Campbell Kathleen M | 4 |
#9 | Sankaram B Mantripragada | 4 |
#10 | Schmidt Paul | 3 |
Publication | Filing date | Title |
---|---|---|
US2016151510A1 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | |
US2016000713A1 | Solvent extraction from biodegradable microparticles | |
BR122016021907B1 | Insulin-peg conjugate, poly (lactidioco-glycolide) microsphere, drug release formulation, and use |